Skip to content
Subscriber Only
Businessweek
Business

George Goldsmith Talks About His Drug for Treating Depression

The Compass Pathways CEO and his physician wife researched the psychoactive ingredient in “magic mushrooms” while seeking to help their son.
 

George Goldsmith

 

George Goldsmith

Source: Compass Pathways

Compass Pathways developed a synthetic form of psilocybin, the psychoactive ingredient found in “magic mushrooms,” for use in treating depression. CEO George Goldsmith says the key is using the hallucinogenic as part of a broader therapy.

● Goldsmith and his physician wife were drawn to research on hallucinogenic mushrooms while seeking a treatment for their son’s mental health issues. ● The Food and Drug Administration designated their work a “breakthrough therapy” in 2018 ● It’s now in Phase II trials